{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T17:37:16Z","timestamp":1782754636616,"version":"3.54.5"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/pas.0b013e31825d9b8d","type":"journal-article","created":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T00:15:55Z","timestamp":1342138555000},"page":"1170-1177","source":"Crossref","is-referenced-by-count":41,"title":["Prediction of BRCA1 Germline Mutation Status in Women With Ovarian Cancer Using Morphology-based Criteria"],"prefix":"10.1097","volume":"36","author":[{"given":"Mika","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A.","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Felberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiva","family":"Sieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice S.","family":"Whittemore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri A.","family":"Longacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210131","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1086\/301749","article-title":"Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.","volume":"62","author":"Ford","year":"1998","journal-title":"Am J Hum Genet"},{"key":"R2-8-20210131","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO;2-Z","article-title":"The genetic attributable risk of breast and ovarian cancer.","volume":"77","author":"Claus","year":"1996","journal-title":"Cancer"},{"key":"R3-8-20210131","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1086\/318787","article-title":"Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.","volume":"68","author":"Risch","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R5-8-20210131","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1002\/(SICI)1097-0142(19981201)83:11<2335::AID-CNCR13>3.0.CO;2-N","article-title":"The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: A population-based study.","volume":"83","author":"Armes","year":"1998","journal-title":"Cancer"},{"key":"R6-8-20210131","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1080\/00313020220147113","article-title":"The pathology of inherited breast cancer.","volume":"34","author":"Armes","year":"2002","journal-title":"Pathology"},{"issue":"suppl 2","key":"R7-8-20210131","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1038\/modpathol.2010.37","article-title":"Pathology of hereditary breast cancer.","volume":"23","author":"Da Silva","year":"2010","journal-title":"Mod Pathol"},{"key":"R8-8-20210131","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/01.pas.0000213273.22844.1a","article-title":"Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing.","volume":"30","author":"Farshid","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R9-8-20210131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cancergencyto.2008.11.003","article-title":"Histopathological criteria and selection algorithms for BRCA1 genetic testing.","volume":"189","author":"Gadzicki","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"R10-8-20210131","first-page":"1206","article-title":"Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancer.","volume":"60","author":"Lidereau","year":"2000","journal-title":"Cancer Res"},{"key":"R11-8-20210131","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.humpath.2006.11.010","article-title":"Recommendations for the reporting of fallopian tube neoplasms.","volume":"38","author":"Longacre","year":"2007","journal-title":"Hum Pathol"},{"key":"R12-8-20210131","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10689-007-9152-x","article-title":"A review of histopathological subtypes of ovarian cancer in BRCA-related french canadian cancer families.","volume":"6","author":"Tonin","year":"2007","journal-title":"Fam Cancer"},{"key":"R14-8-20210131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/01.pgp.0000101083.35393.cd","article-title":"Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.","volume":"23","author":"Werness","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R15-8-20210131","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations.","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R16-8-20210131","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2003.11.009","article-title":"BRCA germline mutations in jewish women with uterine serous papillary carcinoma.","volume":"92","author":"Lavie","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R17-8-20210131","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/aje\/kwh284","article-title":"Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and noncarriers of BRCA1 gene mutations.","volume":"160","author":"McGuire","year":"2004","journal-title":"Am J Epidemiol"},{"key":"R18-8-20210131","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1073\/pnas.86.8.2766","article-title":"Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.","volume":"86","author":"Orita","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"R19-8-20210131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-4608(98)00267-2","article-title":"Mutation analysis of BRCA1, TP53, and KRAS2 in ovarian and related pelvic tumors.","volume":"112","author":"Tworek","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"R20-8-20210131","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/(SICI)1097-0142(19980301)82:5<893::AID-CNCR14>3.0.CO;2-W","article-title":"Toward the development of a universal grading system for ovarian epithelial carcinoma: Testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.","volume":"82","author":"Shimizu","year":"1998","journal-title":"Cancer"},{"key":"R21-8-20210131","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.2011.183","article-title":"Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma.","volume":"25","author":"Soslow","year":"2012","journal-title":"Mod Pathol"},{"key":"R24-8-20210131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","article-title":"Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: Implications for gross examination, cytology, and clinical follow-up.","volume":"26","author":"Agoff","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R25-8-20210131","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":"Occult carcinoma in prophylactic oophorectomy specimens: Prevalence and association with BRCA germline mutation status.","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R26-8-20210131","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.humpath.2005.06.006","article-title":"Hereditary ovarian cancer.","volume":"36","author":"Prat","year":"2005","journal-title":"Hum Pathol"},{"key":"R27-8-20210131","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1097\/PAS.0b013e3181bc6059","article-title":"Multistep level sections to detect occult fallopian tube carcinoma in risk-reducing salpingo-oophorectomies from women with BRCA mutations: implications for defining an optimal specimen dissection protocol.","volume":"33","author":"Rabban","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R28-8-20210131","doi-asserted-by":"crossref","first-page":"5530","DOI":"10.1200\/JCO.2008.16.1703","article-title":"BRCAness syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.","volume":"26","author":"Tan","year":"2008","journal-title":"J Clin Oncol"},{"key":"R29-8-20210131","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","article-title":"The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.","volume":"9","author":"Young","year":"2009","journal-title":"BMC Cancer"},{"key":"R30-8-20210131","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/BD-2010-0306","article-title":"BRCA12 mutations and triple negative breast cancers.","volume":"32","author":"Peshkin","year":"2010","journal-title":"Breast Dis"},{"key":"R31-8-20210131","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ygyno.2007.09.031","article-title":"Society of gynecologic oncologists education committee statement on risk assessment for inherited gynecologic cancer predispositions.","volume":"107","author":"Lancaster","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R32-8-20210131","first-page":"172","article-title":"Hereditary ovarian cancer.","volume":"31","author":"Neri","year":"1995","journal-title":"Isr J Med Sci"},{"key":"R33-8-20210131","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004347-200210000-00011","article-title":"Histopathologic features of genetically determined ovarian cancer.","volume":"21","author":"Shaw","year":"2002","journal-title":"Int J Gynecol Pathol"},{"key":"R34-8-20210131","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system.","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R35-8-20210131","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R36-8-20210131","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","article-title":"Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.","volume":"283","author":"Boyd","year":"2000","journal-title":"JAMA"},{"key":"R37-8-20210131","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/1078-0432.CCR-1029-3","article-title":"Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.","volume":"10","author":"Lakhani","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R38-8-20210131","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0046-8177(00)80014-3","article-title":"Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations.","volume":"31","author":"Werness","year":"2000","journal-title":"Hum Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0b013e31825d9b8d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:57:25Z","timestamp":1620968245000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201208000-00008"}},"subtitle":["Identification of a BRCA1 Ovarian Cancer Phenotype"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e31825d9b8d","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}